SANUWAVE Health (SNWV) Capital Expenditures Growth (3y) (2014 - 2026)
SANUWAVE Health (SNWV) Capital Expenditures Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 2.15% |
| 10 | SANUWAVE Health | 52.23 Mn | 41.45 Mn | 7.43 Mn | 56.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.50% |
| Dec 31, 2025 | -75.71% |
| Dec 31, 2024 | -69.69% |
| Sep 30, 2024 | -33.61% |
| Jun 30, 2024 | -19.45% |
| Mar 31, 2024 | 4.12% |
| Dec 31, 2023 | -141.42% |
| Jun 30, 2023 | -48.57% |
| Mar 31, 2023 | 53.26% |
| Dec 31, 2022 | -148.29% |
| Dec 31, 2021 | 101.75% |
| Sep 30, 2021 | 106.74% |
| Jun 30, 2021 | 210.28% |
| Mar 31, 2021 | 135.63% |
| Dec 31, 2019 | 115.70% |
| Sep 30, 2014 | -29.14% |